Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for Expr_pattern: Expr1737

expand all nodes | collapse all nodes | view schema

Name Class

Expr1737Expression_ofGeneWBGene00004782
Reflects_endogenous_expression_ofWBGene00004782
Expression_dataLife_stageWBls:0000024
WBls:0000003
WBls:0000041
Anatomy_termWBbt:0003681Certain
WBbt:0004017Certain
WBbt:0004575Certain
WBbt:0004576Certain
WBbt:0005772Certain
WBbt:0005784Certain
GO_termGO:0005634
Subcellular_localizationnuclei
TypeAntibodyRat polyclonal antibodies were raised against the N-terminal peptide of SET-2L. The distribution of SET-2L in wild-type worms and embryos was determined by immunostaining.
PatternSET-2L protein is localized in the nuclei of all cells in embryos at all stages of embryogenesis. In L1 larvae, SET-2L remains visible in the nuclei of most cell types but is most prominent in Z2 and Z3, the primordial germ cells. In adults, SET-2L staining is nuclear and is strongest in the germline, although it is also detectable in other cell types, such as intestinal, pharyngeal, and neuronal cells. The level of SET-2L varies in different portions of the gonad. It is present in the distal mitotic cells, diminishes to very low levels in the transition zone and early pachytene regions, and increases dramatically in mid-pachytene nuclei. In oocytes, the level of SET-2L appears relatively low.
PictureWBPicture0000011763
WBPicture0000011764
RemarkThe specificity of the antibodies was demonstrated by the observation that SET-2L immunostaining is reduced to below detection in set-2(RNAi) embryos and worms.
Ubiquitous. The specificity of the antibodies was demonstrated by the observation that SET-2L immunostaining is reduced to below detection in set-2(RNAi) embryos and worms.
ReferenceWBPaper00005020
Antibody_infoWBAntibody00000438